Concepedia

Raymond G. Goodwin

RG

Statistics

Publications

48

Citations

15.4K

H-Index

37

Active since

1985

Affiliations

Research & Development Corporation(Current)

IDEX Corporation (United States)

The University of Texas MD Anderson Cancer Center

Amgen (United States)

Case Western Reserve University

Raymond G. Goodwin is an author at Research & Development Corporation specializing in life sciences, immunology, and signal transduction.

Publications per year

1985–2014

48

Publications

48

Identification and characterization of a new member of the TNF family that induces apoptosis

Steven R. Wiley, Ken Schooley, Pamela J. Smolak et al. · Immunity · 1995 · 2.9K citations · Full text

, , +14

Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

Henning Walczak, Robert E. Miller, K. Ariail et al. · Nature Medicine · 1999 · 2.5K citations

, , +12

A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral Proteins

Craig A. Smith, Terri Davis, Dirk Anderson et al. · Science · 1990 · 964 citations

, , +16

Fas ligand mediates activation-induced cell death in human T lymphocytes.

Mark R. Alderson, Teresa W. Tough, Terri Davis‐Smith et al. · The Journal of Experimental Medicine · 1995 · 949 citations · Full text

, , +17

The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain

Mariapia A. Degli‐Esposti, William C. Dougall, Pamela J. Smolak et al. · Immunity · 1997 · 818 citations · Full text

, , +16

1–5 of 48